Choice of insulin in type 2 diabetes: A Southeast Asian perspective
Southeast Asia faces a diabetes epidemic, which has created significant challenges for health care. The unique Asian diabetes phenotype, coupled with peculiar lifestyle, diet, and healthcare-seeking behavior, makes it imperative to develop clinical pathways and guidelines which address local needs a...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=3;spage=478;epage=481;aulast=Kalra |
id |
doaj-4589b558087c4b90b5e74f6c182b4c10 |
---|---|
record_format |
Article |
spelling |
doaj-4589b558087c4b90b5e74f6c182b4c102020-11-24T22:49:21ZengWolters Kluwer Medknow PublicationsIndian Journal of Endocrinology and Metabolism2230-82102017-01-0121347848110.4103/ijem.IJEM_82_17Choice of insulin in type 2 diabetes: A Southeast Asian perspectiveSanjay KalraHong Quang ThaiChaicharn DeerochanawongGoh Su-YenMafauzy MohamedTint Swe LattThan Than AyeZafar Ahmed LatifPrasad KatulandaTouch KhunSum SathaVadsana VongvandySoutheast Asia faces a diabetes epidemic, which has created significant challenges for health care. The unique Asian diabetes phenotype, coupled with peculiar lifestyle, diet, and healthcare-seeking behavior, makes it imperative to develop clinical pathways and guidelines which address local needs and requirements. From an insulin-centric viewpoint, the preparations prescribed in such pathways should be effective, safe, well tolerated, nonintrusive, and suitable for the use in multiple clinical situations including initiation and intensification. This brief communication describes the utility of premixed or dual action insulin in such clinical pathways and guidelines.http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=3;spage=478;epage=481;aulast=KalraAsiabasal insulinbiphasic aspartbiphasic lisprodiabetesdual action insulinpatient-centered carepostprandial glycemiapremixed insulin |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sanjay Kalra Hong Quang Thai Chaicharn Deerochanawong Goh Su-Yen Mafauzy Mohamed Tint Swe Latt Than Than Aye Zafar Ahmed Latif Prasad Katulanda Touch Khun Sum Satha Vadsana Vongvandy |
spellingShingle |
Sanjay Kalra Hong Quang Thai Chaicharn Deerochanawong Goh Su-Yen Mafauzy Mohamed Tint Swe Latt Than Than Aye Zafar Ahmed Latif Prasad Katulanda Touch Khun Sum Satha Vadsana Vongvandy Choice of insulin in type 2 diabetes: A Southeast Asian perspective Indian Journal of Endocrinology and Metabolism Asia basal insulin biphasic aspart biphasic lispro diabetes dual action insulin patient-centered care postprandial glycemia premixed insulin |
author_facet |
Sanjay Kalra Hong Quang Thai Chaicharn Deerochanawong Goh Su-Yen Mafauzy Mohamed Tint Swe Latt Than Than Aye Zafar Ahmed Latif Prasad Katulanda Touch Khun Sum Satha Vadsana Vongvandy |
author_sort |
Sanjay Kalra |
title |
Choice of insulin in type 2 diabetes: A Southeast Asian perspective |
title_short |
Choice of insulin in type 2 diabetes: A Southeast Asian perspective |
title_full |
Choice of insulin in type 2 diabetes: A Southeast Asian perspective |
title_fullStr |
Choice of insulin in type 2 diabetes: A Southeast Asian perspective |
title_full_unstemmed |
Choice of insulin in type 2 diabetes: A Southeast Asian perspective |
title_sort |
choice of insulin in type 2 diabetes: a southeast asian perspective |
publisher |
Wolters Kluwer Medknow Publications |
series |
Indian Journal of Endocrinology and Metabolism |
issn |
2230-8210 |
publishDate |
2017-01-01 |
description |
Southeast Asia faces a diabetes epidemic, which has created significant challenges for health care. The unique Asian diabetes phenotype, coupled with peculiar lifestyle, diet, and healthcare-seeking behavior, makes it imperative to develop clinical pathways and guidelines which address local needs and requirements. From an insulin-centric viewpoint, the preparations prescribed in such pathways should be effective, safe, well tolerated, nonintrusive, and suitable for the use in multiple clinical situations including initiation and intensification. This brief communication describes the utility of premixed or dual action insulin in such clinical pathways and guidelines. |
topic |
Asia basal insulin biphasic aspart biphasic lispro diabetes dual action insulin patient-centered care postprandial glycemia premixed insulin |
url |
http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=3;spage=478;epage=481;aulast=Kalra |
work_keys_str_mv |
AT sanjaykalra choiceofinsulinintype2diabetesasoutheastasianperspective AT hongquangthai choiceofinsulinintype2diabetesasoutheastasianperspective AT chaicharndeerochanawong choiceofinsulinintype2diabetesasoutheastasianperspective AT gohsuyen choiceofinsulinintype2diabetesasoutheastasianperspective AT mafauzymohamed choiceofinsulinintype2diabetesasoutheastasianperspective AT tintswelatt choiceofinsulinintype2diabetesasoutheastasianperspective AT thanthanaye choiceofinsulinintype2diabetesasoutheastasianperspective AT zafarahmedlatif choiceofinsulinintype2diabetesasoutheastasianperspective AT prasadkatulanda choiceofinsulinintype2diabetesasoutheastasianperspective AT touchkhun choiceofinsulinintype2diabetesasoutheastasianperspective AT sumsatha choiceofinsulinintype2diabetesasoutheastasianperspective AT vadsanavongvandy choiceofinsulinintype2diabetesasoutheastasianperspective |
_version_ |
1725676107356700672 |